TIBET PHARMA(SH:600211) Xin Lang Cai Jing·2025-08-16 02:15Group 1 - The core viewpoint of the article is that Tibet Pharmaceutical (600211.SH) has reported its semi-annual results for 2025, highlighting significant institutional ownership and changes in shareholder composition [1] Group 2 - As of August 15, 2025, a total of 11 institutional investors disclosed holding shares in Tibet Pharmaceutical, with a combined holding of 202 million shares, representing 62.74% of the company's total equity [1] - The top ten institutional investors collectively hold 62.73% of the shares, with a slight decrease of 0.66 percentage points compared to the previous quarter [1] - One new public fund was disclosed during this period, namely Guolian Jingyi 6-Month Holding Mixed A, while two public funds were no longer disclosed, including Chuangjin Hexin Consumer Theme Stock A and Great Wall Quantitative Small Cap Stock A [1] - One social security fund, specifically the Huaxia Fund Management Co., Ltd. - Social Security Fund 422 Combination, reduced its holdings by 0.16% compared to the previous quarter [1]